Altogether, these findings confirm the oncogenic characteristics of the estrogen signaling pathway in PCa, independently of the AR, and emphasize ERα’s potential as a therapeutic target for patients with ERα-positive PCa. Here, ESR1 is linked to posterior cortical atrophy.